Genzyme | GENZ | real-time chart and news
|
|
User-adjustable stock chart (CFD data). Hover the mouse and discover options menu to adjust time scale, time length, format (candle/line/ point and figure).
|
News for Genzyme Corporation - Google Finance
|
| News for Genzyme Corporation - Google Finance |
-
Morgan Joseph Initiates Coverage on Genzyme (GENZ) with a Buy
Morgan Joseph Initiates Coverage on Genzyme (GENZ) with a Buy
StreetInsider.com (subscription) - 10 hours ago
Morgan Joseph initiates coverage on Genzyme (Nasdaq: GENZ) with a Buy rating and an price target. Morgan analyst says, "We like Genzyme because we believe the company has the growth drivers in ...
-
Plerixafor Bags FDA Approval for Improving Stem Cell Yield in Bone Marrow Transplants
-
5 Biotech Stocks To Watch In '09 (DNA, AMGN, GILD, CELG, GENZ)
-
Mozobil™ Approved for Stem Cell Mobilization in NHL and MM Patients
-
Genzyme - a diagnosis
Genzyme - a diagnosis
RTT News - Dec 26, 2008
(RTTNews) - Behind every successful drug that beams with an FDA approval, is a history of high-profile fiascos that will speak of years of fruitless toil and dead-end research…the millions of ...
-
BioCryst names new board member
BioCryst names new board member
Pharmaceutical Business Review - Dec 26, 2008
By Staff Writer Prior to Iomai, he served as president and CEO of Procept, a publicly traded immunology company, as vice president, corporate development at Integrated Genetics (now Genzyme), and ...
|
|